Technical Analysis

technical analysis chart Blue Chips Are Not the Place to Hunt for Bargains

Technical Analysis Stock Chart

Technical analysis scrutinizes equities based on past measurements like asset price and trading volume, which give a view of past performance and stock trends. The technical analysis method does not assign value to a given equity; rather it simply reviews charts and statistical measurement of historical market activity in order to best predict future moves.

Investors should pay close attention to an equity’s direction, speed and distance throughout a technical analysis review. Is the price traveling in an upward or downward direction? What speed is the price moving at? Lastly, what distance will the price travel in a given direction?

Recent Articles

Blue Chips Are Not the Place to Hunt for Bargains

The Dow is so technically damaged its underperformance is likely to continue. More 

Put This Fund at the Top of Your Long-Term Buy List

Despite the recent stock market correction, iShares Nasdaq Biotechnology (IBB) remains in an uptrend. More 

Dead Cat Bounce or the Real Deal?

We saw group rotation from small to big caps, but much technical damage has been done. More 

Devon Energy is a Bottom Fisher’s Delight

Devon Energy (DVN) showed strong buying after what appears to be a selling climax. More 

Market’s ‘Soldiers’ Lead a Mighty Charge Higher

The small- and mid-cap indices triggered multiple buy signals. More 

The Best Undervalued Buys in the Market: Intel (INTC)

Buy the chipmaker between its 200-day moving average and June breakout level. More 

Wild Day Has Small Caps Back in the Lead

The Russell 2000 closed up and was just shy of a key reversal day. More 

The Best Undervalued Buys in the Market: Micron Technology (MU)

The market sell-off hit semi stocks hard, driving Micron Technology (MU) down 20%. More 

Tuesday’s Action Should Trigger a Tradable Rally

Go for the long side, but use stop-loss orders. More 

The Best Undervalued Buys in the Market: Celgene (CELG)

My list begins with a top biotech stock that could run more than 20%. More